Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Bria

Showing results (231-240 of 377) with videos related to

Pageof 38
Sort By:
Journal of Thoracic Disease|November 18, 2024
Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectivesFilippo Lococo, Galal Ghaly, Sara Flamini, et al.
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Breast (Edinburgh, Scotland)|July 11, 2016
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survivalLuisa Carbognin, Isabella Sperduti, Mariangela Ciccarese, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory studyErnesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel MeetingFilippo de Marinis, Andrea Ardizzoni, Ilaria Attili, et al.
Cancer Treatment Reviews|August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 29, 2012
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinomaEleonora Brunello, Matteo Brunelli, Giuseppe Bogina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2017
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant TreatmentSara Pilotto, Isabella Sperduti, Giovanni Leuzzi, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Oncotarget|April 24, 2015
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinomaEmilio Bria, Sara Pilotto, Eliana Amato, et al.
Pageof 38

Showing results (231-240 of 377) with videos related to

Sort By:
Pageof 38
Journal of Thoracic Disease|November 18, 2024
Artificial intelligence applications in personalizing lung cancer management: state of the art and future perspectivesFilippo Lococo, Galal Ghaly, Sara Flamini, et al.
Cancers|June 26, 2026
From Clinical Trials to Real-World Practice: Surgical Feasibility and Postoperative Outcomes After Neoadjuvant Chemoimmunotherapy for Locally Advanced NSCLC in a Single-Center ExperienceFilippo Lococo, Dania Nachira, Khrystyna Kuzmych, et al.
Breast (Edinburgh, Scotland)|July 11, 2016
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survivalLuisa Carbognin, Isabella Sperduti, Mariangela Ciccarese, et al.
Human Vaccines & Immunotherapeutics|March 8, 2022
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory studyErnesto Rossi, Ilaria Grazia Zizzari, Alessandra Di Filippo, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Perioperative Chemo-Immunotherapy in Non-Oncogene-Addicted Resectable Non-Small Cell Lung Cancer (NSCLC): Italian Expert Panel MeetingFilippo de Marinis, Andrea Ardizzoni, Ilaria Attili, et al.
Cancer Treatment Reviews|August 20, 2022
Tailoring neoadjuvant treatment of HR-positive/HER2-negative breast cancers: Which role for gene expression assays?Giovanna Garufi, Luisa Carbognin, Concetta Arcanà, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 29, 2012
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinomaEleonora Brunello, Matteo Brunelli, Giuseppe Bogina, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2017
Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant TreatmentSara Pilotto, Isabella Sperduti, Giovanni Leuzzi, et al.
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.
Oncotarget|April 24, 2015
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinomaEmilio Bria, Sara Pilotto, Eliana Amato, et al.
Pageof 38